News & Events News & Announcements 2017 SSO Applauds Provincial Government's New Drug Benefit Program

SSO Applauds Provincial Government's New Drug Benefit Program

(Premier Kathleen Wynne with SSO policy analyst, Antonella Scail (right)
The Schizophrenia Society of Ontario applauds the provincial government's recent investment in a new drug benefit program which fully covers the cost of prescription medications for young people under the age of 25. With no deductible or 
copayment, the OHIP+: Children and Youth Pharmacare Program will help ensure that eligible people who use prescription medications will not face barriers related to lack of insurance coverage or inability to pay out-of-pocket for medications that are available through the Ontario Drug Benefit Program. 

“Access to timely, affordable and effective pharmacare is an issue that significantly affects individuals, families and communities impacted by severe and chronic mental illness,” says Mary Alberti, Schizophrenia Society of Ontario CEO. “The budget announcement is as a step in the right direction to ensure that Ontarians are able to access a range of mental health treatments and supports that are right for them. We look forward to working with the province as it moves towards a universal program to ensure access for all.”

To read the official OHIP+ announcement, click here.